Hyperlipoproteinemia Type 4 Overview

Save information for later
Sign Up

Learn About Hyperlipoproteinemia Type 4

What is the definition of Hyperlipoproteinemia Type 4?
Hyperlipoproteinemia Type IV, also known as carbohydrate-inducible hyperlipemia, is a condition in which an individual has high levels of very low-density lipoprotein (LDL) cholesterol and triglycerides (types of fat) in their blood. High levels of very low-density lipoprotein cholesterol and triglycerides can cause atherosclerosis, or the build-up of plaques of fatty cholesterol in the artery walls, which can lead to heart disease or stroke. Hyperlipoproteinemia Type IV is believed to occur in individuals who have a genetic predisposition for the disease and from consuming carbohydrates and alcohol.
What are the symptoms of Hyperlipoproteinemia Type 4?
Hyperlipoproteinemia may not cause any symptoms or may cause hypertriglyceridemic waist, which is an elevated waist circumference (>90 cm in men or >85 cm in women).
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Hyperlipoproteinemia Type 4?
Treatment for hyperlipoproteinemia Type IV includes the use of metformin, a medication that lowers blood glucose (sugar); atorvastatin, a drug that lowers blood cholesterol levels; and chenodeoxycholic acid, a bile acid that lowers the production of cholesterol in the liver and its absorption in the small intestine.
Who are the top Hyperlipoproteinemia Type 4 Local Doctors?
Distinguished in Hyperlipoproteinemia Type 4
Dr. Charles D. Christian
Internal Medicine
Distinguished in Hyperlipoproteinemia Type 4
Dr. Charles D. Christian
Internal Medicine

Indiana University Health Care Associates Inc

820 N Samuel Moore Pkwy, Suite A, 
Mooresville, IN 
317-944-3500
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Charles Christian is a primary care provider, practicing in Internal Medicine in Mooresville, Indiana. Dr. Christian is rated as a Distinguished provider by MediFind in the treatment of Hyperlipoproteinemia Type 4. His top areas of expertise are Heterozygous Familial Hypercholesterolemia (HeFH), Hyperlipoproteinemia Type 4, Familial Hypercholesterolemia, and Defective Apolipoprotein B-100. Dr. Christian is currently accepting new patients.

Distinguished in Hyperlipoproteinemia Type 4
Dr. Thomas E. Dunlap
Cardiology
Distinguished in Hyperlipoproteinemia Type 4
Dr. Thomas E. Dunlap
Cardiology
500 Doyle Park Drive, Suite G05, 
Santa Rosa, CA 
707-303-8336
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Thomas Dunlap is a Cardiologist in Santa Rosa, California. Dr. Dunlap is rated as a Distinguished provider by MediFind in the treatment of Hyperlipoproteinemia Type 4. His top areas of expertise are Arrhythmias, Hyperlipoproteinemia Type 4, Heterozygous Familial Hypercholesterolemia (HeFH), Defective Apolipoprotein B-100, and Pacemaker Implantation. Dr. Dunlap is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Hyperlipoproteinemia Type 4
Dr. Daniel E. Soffer
Cardiology
Distinguished in Hyperlipoproteinemia Type 4
Dr. Daniel E. Soffer
Cardiology

Penn Heart And Vascular Center

3400 Civic Center Boulevard, East Pavilion, 2nd Floor, 
Philadelphia, PA 
215-615-4949
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Daniel Soffer is a Cardiologist in Philadelphia, Pennsylvania. Dr. Soffer is rated as a Distinguished provider by MediFind in the treatment of Hyperlipoproteinemia Type 4. His top areas of expertise are High Cholesterol, Hyperlipoproteinemia Type 4, Defective Apolipoprotein B-100, and Heterozygous Familial Hypercholesterolemia (HeFH). Dr. Soffer is currently accepting new patients.

View All Doctors
What are the latest Hyperlipoproteinemia Type 4 Clinical Trials?
A Multi-center, Open Label, Multi-arm, Dose Ascending Clinical Trial for Evaluation of Safety and Tolerance of Gene Therapy Drug GC304 in the Treatment of Primary Hypertriglyceridemia Patients With History of Acute Pancreatitis
A Multi-center, Open Label, Multi-arm, Dose Ascending Clinical Trial for Evaluation of Safety and Tolerance of Gene Therapy Drug GC304 in the Treatment of Primary Hypertriglyceridemia Patients With History of Acute Pancreatitis
Enrollment Status: Recruiting
Publish Date: July 03, 2025
Intervention Type: Genetic
Study Phase: Phase 1

Summary: The study will evaluate safety and tolerance of intravenous delivery of GC304 gene therapy drug as a treatment of primary hypertriglyceridemic patients with previous onset of acute pancreatitis.

Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials